Body Weight-Dependent Pharmacokinetics of Busulfan in Paediatric Haematopoietic Stem Cell Transplantation Patients

Fludarabine + Exposure-Targeted Busulfan in Children with Malignant and Non-Malignant Diseases: An Effective and Low Toxic Regimen

(2012) J.J. Boelens et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Busulfan Dosing in Children with BMIs ≥85% Undergoing HSCT: A New Optimal Strategy

(2011) Brittan Browning et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Accurate Targeting of Daily Intravenous Busulfan with 8-Hour Blood Sampling in Hospitalized Adult Hematopoietic Cell Transplant Recipients

(2011) Rosa F. Yeh et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Population Pharmacokinetics of Busulfan in Children: Increased Evidence for Body Surface Area and Allometric Body Weight Dosing of Busulfan in Children

(2011) M. N. Trame et al.   CLINICAL CANCER RESEARCH

Lidocaine (Lignocaine) Dosing Regimen Based upon a Population Pharmacokinetic Model for Preterm and Term Neonates with Seizures

(2011) Marcel P.H. van den Broek et al.   CLINICAL PHARMACOKINETICS

Successful Half-Dose Busulfan/Full-Dose Fludarabine Based Reduced Intensity Conditioning In High-Risk Pediatric And Adult Chronic Granulomatous Disease (CGD) Patients

(2010) T. Güngör et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Clofarabine±Fludarabine With IV Busulfan And Allogeneic Stem Cell Transplantation For Relapsed, Refractory Myeloid Leukemia (ML) And MDS

(2010) B.S. Andersson et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Novel pharmacokinetic behavior of intravenous busulfan in children with thalassemia undergoing hematopoietic stem cell transplantation: a prospective evaluation of pharmacokinetic and pharmacodynamic profile with therapeutic drug monitoring

(2010) J. Gaziev et al.   BLOOD

Systematic Evaluation of the Descriptive and Predictive Performance of Paediatric Morphine Population Models

(2010) Elke H. J. Krekels et al.   PHARMACEUTICAL RESEARCH

Handling Data Below the Limit of Quantification in Mixed Effect Models

(2009) Martin Bergstrand et al.   AAPS Journal

Association between Busulfan Exposure and Outcome in Children Receiving Intravenous Busulfan before Hematologic Stem Cell Transplantation

(2009) Imke H. Bartelink et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Busulfan in Hematopoietic Stem Cell Transplantation

(2009) Stefan O. Ciurea et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313

(2009) M. A. Pulsipher et al.   BLOOD

Age-dependent pharmacokinetic profile of single daily dose i.v. busulfan in children undergoing reduced-intensity conditioning stem cell transplant

(2009) W T Tse et al.   BONE MARROW TRANSPLANTATION

Morphine Glucuronidation in Preterm Neonates, Infants and Children Younger than 3 Years

(2009) Catherijne A.J. Knibbe et al.   CLINICAL PHARMACOKINETICS

High Busulfan Exposure Is Associated with Worse Outcomes in a Daily i.v. Busulfan and Fludarabine Allogeneic Transplant Regimen

(2008) Michelle Geddes et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Once Daily i.v. Busulfan and Fludarabine (i.v. Bu-Flu) Compares Favorably with i.v. Busulfan and Cyclophosphamide (i.v. BuCy2) as Pretransplant Conditioning Therapy in AML/MDS

(2008) Borje S. Andersson et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Variability in the pharmacokinetics of intravenous busulphan given as a single daily dose to paediatric blood or marrow transplant recipients

(2008) Christa E. Nath et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Therapeutic Drug Monitoring of Busulfan in Transplantation

(2008) J. Russell et al.   CURRENT PHARMACEUTICAL DESIGN

Mechanism-Based Concepts of Size and Maturity in Pharmacokinetics

(2007) B.J. Anderson et al.   Annual Review of Pharmacology and Toxicology

Once-Daily Intravenous Busulfan with Therapeutic Drug Monitoring Compared to Conventional Oral Busulfan Improves Survival and Engraftment in Children Undergoing Allogeneic Stem Cell Transplantation

(2007) Imke H. Bartelink et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION